Literature DB >> 11985905

Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation.

Emanuele Antonielli1, Alfredo Pizzuti, Attila Pálinkás, Mattia Tanga, Noèmi Gruber, Claudio Michelassi, Albert Varga, Alessandro Bonzano, Nicola Gandolfo, László Halmai, Antonia Bassignana, Muhammad Babar Imran, Fabrizio Delnevo, Miklós Csanády, Eugenio Picano.   

Abstract

OBJECTIVES: This study evaluated the role of various clinical and echocardiographic parameters, including the left atrial appendage (LAA) anterograde flow velocity, for prediction of the long-term preservation of sinus rhythm (SR) in patients with successful cardioversion (CV) of nonvalvular atrial fibrillation (AF).
BACKGROUND: Echocardiographic parameters for assessing long-term SR maintenance after successful CV of nonvalvular AF are not accurately defined.
METHODS: Clinical, transthoracic echocardiographic and transesophageal echocardiographic (TEE) data--measured in AF lasting >48 h--of 186 consecutive patients (116 men, mean age: 65 +/- 9 years) with successful CV (electrical or pharmacologic) were analyzed for assessment of one-year maintenance of SR.
RESULTS: At one-year follow-up, 91 of 186 (49%) patients who underwent successful CV continued to have SR. Mean LAA peak emptying flow velocity was higher in patients remaining in SR for one year than in those with AF relapse (41.7 +/- 20.2 cm/s vs. 27.7 +/- 17.0 cm/s; p < 0.001). On multivariate logistic regression analysis, only the mean LAA peak emptying velocity >40 cm/s (p = 0.0001; chi(2): 23.9, odds ratio [OR] = 5.2, confidence interval [CI] 95% = 2.7 to 10.1) and the use of preventive antiarrhythmic drug treatment (p = 0.0398; chi(2): 4.2; OR = 2.0, CI 95% = 1.0 to 3.8) predicted the continuous preservation of SR during one year, outperforming other univariate predictors such as absence of left atrial spontaneous echocardiographic contrast during TEE, the left atrial parasternal diameter <44 mm, left ventricular ejection fraction >46% and AF duration <1 week before CV. The negative and positive predictive values of the mean LAA peak emptying velocity >40 cm/s for assessing preservation of SR were 66% (CI 95% = 56.9 to 74.2) and 73% (CI 95% = 62.4 to 83.3), respectively.
CONCLUSIONS: In TEE-guided management of nonvalvular AF, high LAA flow velocity identifies patients with greater likelihood to remain in SR for one year after successful CV. Low LAA velocity is of limited value in identifying patients who will relapse into AF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11985905     DOI: 10.1016/s0735-1097(02)01800-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

Review 1.  Clinical applications of intracardiac echocardiography in interventional procedures.

Authors:  M R M Jongbloed; M J Schalij; K Zeppenfeld; P V Oemrawsingh; E E van der Wall; J J Bax
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 2.  Identification, diagnosis and assessment of atrial fibrillation.

Authors:  R I Dewar; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

3.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Clinical significance of anterior mitral leaflet fibrillation in patients with nonvalvular atrial fibrillation: comparison with blood flow and wall motion of the left atrial appendage.

Authors:  Yamato Fukuda; Nobuo Fukuda; Koichi Sakabe; Satofumi Morishita; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  J Echocardiogr       Date:  2009-03-18

5.  A novel method to estimate blood flow velocity in the left atrial appendage using enhanced computed tomography: role of Hounsfield unit density ratio at two distinct points within the left atrial appendage.

Authors:  Ryobun Yasuoka; Takashi Kurita; Yasuhito Kotake; Yuzuru Akaiwa; Naotaka Hashiguchi; Koichiro Motoki; Hiromi Yamamoto; Kazuhiro Kobuke; Yoshitaka Iwanaga; Yutaka Hirano; Shunichi Miyazaki
Journal:  Heart Vessels       Date:  2017-01-27       Impact factor: 2.037

Review 6.  The Role of Echocardiography as a Predictor of the Incidence and Progression of Atrial Fibrillation.

Authors:  Rui Providência; Sérgio Barra; Luís Paiva
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 7.  Role of Echocardiography in the Management and Prognosis of Atrial Fibrillation.

Authors:  David I Silverman; Srilatha R Ayirala; Warren J Manning
Journal:  J Atr Fibrillation       Date:  2012-02-02

8.  The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin Therapy.

Authors:  Neil Herring; Stephen P Page; Mohammed Ahmed; Melanie R Burg; Ross J Hunter; Mark J Earley; Simon C Sporton; James D Newton; Nikant K Sabharwal; Saul G Myerson; Yaver Bashir; Tim R Betts; Richard J Schilling; Kim Rajappan
Journal:  J Atr Fibrillation       Date:  2013-04-06

9.  Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation.

Authors:  Pedro Pinto Teixeira; Mário Martins Oliveira; Ruben Ramos; Pedro Rio; Pedro Silva Cunha; Ana Sofia Delgado; Ricardo Pimenta; Rui Cruz Ferreira
Journal:  J Interv Card Electrophysiol       Date:  2017-05-31       Impact factor: 1.900

10.  Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.

Authors:  Xin-Xin Ma; Yue-Li Zhang; Bing Hu; Wen-Jun Jiang; Man Wang; Dong-Yan Zheng; Meng-Ruo Zhu; Xiao-Pei Xue
Journal:  J Interv Card Electrophysiol       Date:  2016-12-12       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.